HOME >> MEDICINE >> NEWS
Study shows use of budesonide reduced the risk of asthma related events by 40% in children

San Antonio, Tex., - March 19, 2005 New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication.

The findings, presented today at the 61st annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), are from two analyses of the Inhaled Steroid as Regular Therapy in Early Asthma (START) study, a three-year trial involving nearly 2,000 children aged 5 to 10 years with mild persistent asthma. The START study was funded by AstraZeneca.

"Many children with asthma make repeated trips to the emergency room or are hospitalized because of worsening symptoms," said Dr. Albert Sheffer, Clinical Professor of Medicine at Harvard Medical School, Director Emeritus at the Allergy Clinic, Brigham and Women's Hospital in Boston and an investigator in the safety and tolerability portion of the study. "The findings of these two analyses showed that budesonide had a viable long-term treatment effect."

In the first analysis, 1,974 children were randomized to receive either once-daily budesonide or placebo in addition to usual asthma care. The earlier use of budesonide reduced the risk of exacerbation, or severe asthma related events by 40 percent compared to usual asthma care. In addition, children in the budesonide group required fewer interventions with other inhaled corticosteroids (12.3 percent versus 22.7 percent for placebo), and had improved lung function.

The second analysis tracked the adverse side effects reported by 1,981 children taking either budesonide plus usual care or placebo over three years. Overall, the incidence of side effects was comparable between the two groups, with fewer asthma exacerbations and adverse events reported in the budesonide group throughout
'"/>

Contact: Heather Law
heather.law@astrazeneca.com
302-886-1652
Burson-Marsteller
21-Mar-2005


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
10. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women
11. Study of obese diabetics explains why low-carb diets produce fast results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/2/2020)... Pa. (PRWEB) , ... September 02, 2020 , ... ... of enterprise software for healthcare payers administering Medicare Advantage and Special Needs plans, ... Online presented by America’s Health Insurance Plans (AHIP). RAM is supporting the event ...
(Date:9/1/2020)... , ... September 01, 2020 , ... As fall and ... the Cohn Health Institute has taken this time to expand and grow ... its 30th Anniversary, the Cohn Health Institute will be relaunching its brand new website, ...
(Date:8/31/2020)... ... , ... Just found out your dear friend has cancer? , It’s hard to hear your ... shares their diagnosis. Once the shock wears off, the questions and fears can be overwhelming. ... best ways to help? Words are failing me. I’m scared. I want to DO something. ...
(Date:8/31/2020)... ... August 31, 2020 , ... Colorado State University Global ... and affordable online education – is proud to announce its new master’s degree ... of its kind in the nation, the 60-credit hour program is designed to ...
(Date:8/31/2020)... ... ... In an effort to give back to the community in which it serves, ... with a special new rate code to benefit children and families at Ronald ... will be applied to any room type, any time, now through the end of ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... ... September 02, 2020 , ... ... , Advanced Penetration Technology, LLC, (APT) a Texas- and Indiana-based company ( ... Over The Counter (OTC) products, was today provided results of an independent ...
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein Velez, ... at the University of Rochester Medical Center, in Upstate New York. She completed ... with clinical faculty from the Harvard and Yale Departments of Dermatology and is ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... Breast and ... of Disease Control (CDC), About 3% of breast cancers (about 7,500 women per year) ... in the BRCA1 and BRCA2 genes. Both genes are detectable in the Women’s ...
Breaking Medicine Technology:
Cached News: